Home | Business News | Browse by Publication | M | M2 Presswire

Topical gel set to offer welcome relief for Urinary Incontinence sufferers.

Article Excerpt
M2 PRESSWIRE-31 January 2008-DATAMONITOR: Topical gel set to offer welcome relief for Urinary Incontinence sufferers(C)1994-2008 M2 COMMUNICATIONS LTD

RDATE:01022008

London -- Urinary incontinence (UI) is a common but often embarrassing and potentially socially debilitating condition affecting 200 million patients across the seven major markets*. UI is more likely to affect the female population, and is especially prevalent amongst the elderly. Although the prevalence of UI is high, in part because of the social stigma attached to the condition, treatment rates are traditionally low, with many patients receiving no pharmacological therapy at all. Many patients will be self-diagnosed and those with milder symptoms will use pads and behavioral techniques, while some of the most severely-affected patients will seek surgical intervention. No significant improvement has been made in the standard of UI drug treatment in 20 years, however, according to a new report by independent market analyst Datamonitor** an easy to use gel which avoids the side effects and pill burden associated with currently available drugs, will soon be on the market.

Old Anticholinergic drugs dominate the market

UI involves the involuntary leakage of urine, which can be leakage accompanied by or immediately preceded by urgency (urge UI), leakage on exertion (stress...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!